BioBay Center To Help Medtech Firms Enter China
This article was originally published in PharmAsia News
Executive Summary
With the aim of helping western companies tap into the fast-growing Chinese healthcare market, a new cross-border medical technology commercialization center planned in the Suzhou BioBay cluster will provide funding and assistance to selected U.S. and European companies for all aspects of product registration and commercialization in China.